3.39
price up icon4.95%   0.16
after-market After Hours: 3.40 0.010 +0.29%
loading

Puma Biotechnology Inc Stock (PBYI) Latest News

pulisher
Nov 28, 2024

Should Value Investors Buy Puma Biotechnology (PBYI) Stock? - Yahoo Finance

Nov 28, 2024
pulisher
Nov 24, 2024

Puma Biotechnology (NASDAQ:PBYI) Downgraded by StockNews.com to Buy - MarketBeat

Nov 24, 2024
pulisher
Nov 22, 2024

PBYI Begins Phase II Study on Alisertib Combo in Breast Cancer - MSN

Nov 22, 2024
pulisher
Nov 21, 2024

Puma commences Phase II trial of alisertib for breast cancer treatment - Clinical Trials Arena

Nov 21, 2024
pulisher
Nov 20, 2024

Puma Biotech Launches Phase 2 Trial for Advanced Breast Cancer Treatment | PBYI Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 17, 2024

245,695 Shares in Puma Biotechnology, Inc. (NASDAQ:PBYI) Bought by Los Angeles Capital Management LLC - MarketBeat

Nov 17, 2024
pulisher
Nov 14, 2024

Puma Biotechnology's (NASDAQ:PBYI) Performance Is Even Better Than Its Earnings Suggest - Simply Wall St

Nov 14, 2024
pulisher
Nov 14, 2024

We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative - Yahoo Finance

Nov 14, 2024
pulisher
Nov 13, 2024

Puma Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024
pulisher
Nov 09, 2024

Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 09, 2024
pulisher
Nov 09, 2024

Puma Biotechnology, Inc. (NASDAQ:PBYI) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024
pulisher
Nov 08, 2024

Earnings call: Puma Biotechnology reports robust Q3 growth - Investing.com

Nov 08, 2024
pulisher
Nov 08, 2024

Earnings call: Puma Biotechnology reports robust Q3 growth By Investing.com - Investing.com UK

Nov 08, 2024
pulisher
Nov 08, 2024

Puma Biotechnology's (PBYI) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up - Nasdaq

Nov 08, 2024
pulisher
Nov 07, 2024

Puma Biotechnology Reports Strong Q3 2024 Growth - TipRanks

Nov 07, 2024
pulisher
Nov 07, 2024

Puma Biotechnology Q3 2024 Earnings Preview - MSN

Nov 07, 2024
pulisher
Nov 07, 2024

Puma Biotech (PBYI) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

Puma Biotechnology Reports Third Quarter 2024 Financial Results - sharewise

Nov 07, 2024
pulisher
Nov 07, 2024

Puma Biotech: Q3 Earnings Snapshot - San Francisco Chronicle

Nov 07, 2024
pulisher
Nov 05, 2024

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - sharewise

Nov 05, 2024
pulisher
Nov 05, 2024

Puma Biotechnology Grants 5,625-Share Inducement Award to New Employee | PBYI | PBYI Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 01, 2024

Puma Biotechnology (NASDAQ:PBYI) Raised to "Strong-Buy" at StockNews.com - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

Puma Biotechnology (PBYI) Set to Announce Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2024
pulisher
Oct 29, 2024

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Puma Biotechnology, Inc. (NASDAQ - The Bakersfield Californian

Oct 29, 2024
pulisher
Oct 28, 2024

3 US Penny Stocks With Market Caps Under $700M - Simply Wall St

Oct 28, 2024
pulisher
Oct 24, 2024

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results - BioSpace

Oct 24, 2024
pulisher
Oct 23, 2024

Puma Biotechnology (NASDAQ:PBYI) Rating Increased to Strong-Buy at StockNews.com - MarketBeat

Oct 23, 2024
pulisher
Oct 21, 2024

What is Zacks Research's Forecast for PBYI FY2026 Earnings? - MarketBeat

Oct 21, 2024
pulisher
Oct 18, 2024

Equities Analysts Offer Predictions for PBYI Q3 Earnings - MarketBeat

Oct 18, 2024
pulisher
Oct 13, 2024

With A Return On Equity Of 18%, Has Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Management Done Well? - Yahoo Finance

Oct 13, 2024
pulisher
Oct 05, 2024

Puma Biotechnology quickly drops after patents for Tagrisso ruled invalid - MSN

Oct 05, 2024
pulisher
Sep 30, 2024

FY2025 EPS Estimates for Puma Biotechnology, Inc. (NASDAQ:PBYI) Decreased by Zacks Research - MarketBeat

Sep 30, 2024
pulisher
Sep 29, 2024

Frazier Life Sciences Management L.P. Purchases 246,264 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - MarketBeat

Sep 29, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Makes New $815,000 Investment in Puma Biotechnology, Inc. (NASDAQ:PBYI) - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Fred Alger Management LLC Raises Stake in Hamilton Lane Incorporated (NASDAQ:HLNE) - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Hsbc Holdings PLC Has $4.29 Million Position in Grupo Financiero Galicia S.A. (NASDAQ:GGAL) - MarketBeat

Sep 25, 2024
pulisher
Sep 24, 2024

The growth track for Humacyte Inc (HUMA) has changed recently - SETE News

Sep 24, 2024
pulisher
Sep 24, 2024

Humacyte: Navigating The FDA Uncertainty And ATEV’s Potential (NASDAQ:HUMA) - Seeking Alpha

Sep 24, 2024
pulisher
Sep 24, 2024

Puma VCT 13 Launches £70M Share Offer - TipRanks

Sep 24, 2024
pulisher
Sep 23, 2024

HUTCHMED (NASDAQ:HCM) Shares Gap Down to $17.38 - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

It is Poised to be a Bull Market for Puma Biotechnology Inc (PBYI) - SETE News

Sep 23, 2024
pulisher
Sep 22, 2024

American Century Companies Inc. Sells 186,924 Shares of Foot Locker, Inc. (NYSE:FL) - Defense World

Sep 22, 2024
pulisher
Sep 20, 2024

Bank of America Raises Trupanion (NASDAQ:TRUP) Price Target to $56.00 - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Achilles Thera shifts focus to new cancer treatment avenues - The Pharma Letter

Sep 20, 2024
pulisher
Sep 19, 2024

Insider Selling: Sebelius Kathleen, Humacyte Inc [HUMA] Director divested 5,182 shares - Knox Daily

Sep 19, 2024
pulisher
Sep 19, 2024

A$AP Rocky’s Lineup of Puma Sneakers Is Quickly Growing Bigger - Yahoo! Voices

Sep 19, 2024
$21.50
price up icon 1.61%
$74.59
price down icon 1.14%
$370.49
price down icon 2.02%
$43.06
price down icon 0.76%
$215.00
price up icon 4.29%
$118.39
price down icon 1.93%
Cap:     |  Volume (24h):